38P Assessment of lipidomic profile in endocrine receptor-positive (ER+) MBC patients treated with CDK 4/6 inhibitors (CDKi) and endocrine therapy (ET)

A. Gennari, M. Manfredi, E. Barberis, C. Branni, R. Ben Ayed, S. Gobbato, R. Alsati,A. Stella,V. Rossi, F. Platini, B. Ruffilli, V. Martini

ESMO Open(2023)

引用 0|浏览2
暂无评分
关键词
lipidomic profile,endocrine therapy,cdk,mbc patients,receptor-positive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要